Quest Partners LLC Has $56,000 Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Quest Partners LLC trimmed its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 92.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 579 shares of the health services provider's stock after selling 6,759 shares during the period. Quest Partners LLC's holdings in Amedisys were worth $56,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AMED. Alpine Associates Management Inc. grew its position in shares of Amedisys by 0.9% in the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider's stock valued at $117,586,000 after purchasing an additional 11,000 shares during the period. Dimensional Fund Advisors LP grew its holdings in Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock valued at $47,202,000 after buying an additional 19,660 shares during the period. Calamos Advisors LLC increased its stake in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider's stock valued at $36,476,000 after acquiring an additional 41,220 shares during the last quarter. Highbridge Capital Management LLC lifted its holdings in shares of Amedisys by 34.7% during the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider's stock worth $29,670,000 after acquiring an additional 83,200 shares during the period. Finally, SG Americas Securities LLC boosted its position in shares of Amedisys by 413.4% in the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider's stock worth $18,985,000 after acquiring an additional 158,398 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Trading Up 0.2 %

Amedisys stock traded up $0.18 during trading on Friday, reaching $91.41. The company had a trading volume of 107,958 shares, compared to its average volume of 580,939. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 1.92 and a beta of 0.78. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a 12-month low of $88.81 and a 12-month high of $98.95. The stock's 50 day moving average price is $94.74 and its two-hundred day moving average price is $95.62.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.98 EPS. As a group, equities analysts expect that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.